Tuning the Brightness and Photostability of Organic Dots for Multivalent Targeted Cancer Imaging and Surgery.

Abstract

Specific labeling of biomarkers with bright and high photostable fluorophores is vital in fluorescent imaging applications. Here, we report a general strategy to develop single-molecule dendritic nanodots with finely tunable optical properties for <i>in vivo</i> fluorescent imaging. The well-defined nanodots are based on the divergent growth of biodegradable polylysine dendrimers with a fluorophore as the core. By tuning the size and surface chemistry, we obtained fluorescent nanodots with excellent brightness and photostability, favorable pharmacokinetics, and multivalent tumor-targeting capability. The nanodots provided robust, stable, long-lasting, and specific fluorescence enhancement in tumor tissue with an <i>in situ</i> tumor-to-normal ratio (TNR) of ∼3 and lasting over 5 days and an <i>ex vivo</i> TNR up to ∼17, holding considerable promise for cancer imaging and image-guided surgery. This strategy significantly improves the <i>in vivo</i> performance of fluorophores and can be applied to other modality imaging probes.